Search details
1.
Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up.
Blood
; 142(21): 1784-1788, 2023 11 23.
Article
in English
| MEDLINE | ID: mdl-37595283
2.
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
N Engl J Med
; 380(22): 2095-2103, 2019 05 30.
Article
in English
| MEDLINE | ID: mdl-31141631
3.
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Gastroenterology
; 157(5): 1413-1428.e11, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31352001
4.
Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia.
Cancer
; 125(10): 1665-1673, 2019 05 15.
Article
in English
| MEDLINE | ID: mdl-30668890
5.
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.
Blood
; 127(3): 303-9, 2016 Jan 21.
Article
in English
| MEDLINE | ID: mdl-26492934
6.
Targeting BTK through microRNA in chronic lymphocytic leukemia.
Blood
; 128(26): 3101-3112, 2016 12 29.
Article
in English
| MEDLINE | ID: mdl-27756747
7.
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
Cancer
; 123(22): 4430-4439, 2017 Nov 15.
Article
in English
| MEDLINE | ID: mdl-28708931
8.
Arginine addiction in AML.
Blood
; 125(26): 3971-2, 2015 Jun 25.
Article
in English
| MEDLINE | ID: mdl-26113532
9.
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab).
Blood
; 124(20): 3059-64, 2014 Nov 13.
Article
in English
| MEDLINE | ID: mdl-25281606
10.
Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.
Bioorg Med Chem Lett
; 26(8): 2092-7, 2016 Apr 15.
Article
in English
| MEDLINE | ID: mdl-26951751
11.
TRIM24 links a non-canonical histone signature to breast cancer.
Nature
; 468(7326): 927-32, 2010 Dec 16.
Article
in English
| MEDLINE | ID: mdl-21164480
12.
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.
Phys Biol
; 11(6): 065002, 2014 Nov 26.
Article
in English
| MEDLINE | ID: mdl-25427073
13.
Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.
Blood
; 117(1): 156-64, 2011 Jan 06.
Article
in English
| MEDLINE | ID: mdl-20971952
14.
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study.
Lancet Oncol
; 13(11): 1096-104, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-23075701
15.
Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.
Blood
; 116(10): 1737-46, 2010 Sep 09.
Article
in English
| MEDLINE | ID: mdl-20479284
16.
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.
Blood
; 116(6): 945-52, 2010 Aug 12.
Article
in English
| MEDLINE | ID: mdl-20393129
17.
Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks.
Chin J Cancer
; 31(8): 373-80, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22739266
18.
Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells.
Leukemia
; 36(6): 1596-1608, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35383271
19.
DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor.
Mol Pharmacol
; 80(2): 321-7, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21546556
20.
Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels.
J Biol Chem
; 285(11): 8022-30, 2010 Mar 12.
Article
in English
| MEDLINE | ID: mdl-20064937